Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy.
D000328:Adult; D003176:Complement C3 / Q000235:genetics*; D003181:Complement C4 / Q000235:genetics*; D005260:Female; D005819:Genetic Markers; D005922:Glomerulonephritis, IGA / Q000175:diagnosis*; D006680:HLA Antigens / Q000032:analysis*; D015235:HLA-B Antigens; D015797:HLA-B35 Antigen; D059948:HLA-B44 Antigen; D006681:HLA-D Antigens / Q000032:analysis*; D006684:HLA-DR Antigens / Q000032:analysis*; D015798:HLA-DR1 Antigen; D015804:HLA-DR4 Antigen; D006801:Humans; D008297:Male; D010641:Phenotype; D011379:Prognosis
D003176:Complement C3; D003181:Complement C4; D005819:Genetic Markers; D006680:HLA Antigens; D015235:HLA-B Antigens; D015797:HLA-B35 Antigen; D059948:HLA-B44 Antigen; D006681:HLA-D Antigens; D006684:HLA-DR Antigens; D015798:HLA-DR1 Antigen; D015804:HLA-DR4 Antigen